Biogen licenses a possible immune drug from OrbiMed-backed biotech
Biogen Licenses Immune Drug from Vanqua Bio Biogen has licensed a preclinical immune drug from Vanqua Bio, a biotech company backed by OrbiMed, in a deal worth over $1 billion. The …
Biogen Licenses Immune Drug from Vanqua Bio Biogen has licensed a preclinical immune drug from Vanqua Bio, a biotech company backed by OrbiMed, in a deal worth over $1 billion. The …
Iowa Officials Accused of "Sweetheart Deal" with Meatpacker An environmental group alleges that Iowa officials secretly fast-tracked a leg…
Nothing Adds Bloatware to Phones for Revenue Nothing started rolling out the first Nothing OS 4.0 beta build to its Phone 3a series, but u…
Truck Driver in California Crash Charged with Manslaughter A truck driver, identified as 21-year-old Jashanpreet Singh, was charged with g…
La-Na Fragomeni Leads Sault Ste. Marie Chamber of Commerce La-Na Fragomeni, president of Arthur Funeral Home, has been appointed as the ne…
Reforms to Strengthen Disability Rights in Ghana President John Dramani Mahama has announced a comprehensive set of reforms to modernize G…
President Mahama's Initiative for Persons with Disabilities President John Mahama has announced a plan to distribute motorised wheelchairs…
Denver Mayor Extends Flock Camera Contract Amidst Public Outcry Denver residents are demanding answers from Mayor Mike Johnston after he e…
Nana Konadu's Passing: A Moment of National Reflection Minister of Education, Haruna Iddrisu, has described the passing of former First La…
Mahama Vows Support for Persons with Disabilities President John Dramani Mahama has announced measures to promote economic empowerment for…